Found 9 matching trials
SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer PHASE2 This is an open-label, phase II study evaluating the efficacy and safety of...
Show More Location
Shengjing Hospital affiliated to China Medical University
Learn More & Join Trial
A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma PHASE3 This study aims to evaluate the efficacy and safety of SHR-A1811 combined w...
Show More Location
The First Hospital of China Medical University
Learn More & Join Trial
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer PHASE2 The goal of this clinical trial is to learn if add SHR-A1811 and/or Adebrel...
Show More Location
National Cancer Center/Cancer hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer PHASE1 The objective is to evaluate the tolerance, safety, pharmacokinetic charact...
Show More Location
Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer PHASE2 The study is being conducted to evaluate the efficacy, safety, and ORR of H...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer PHASE2 To evaluate the safety, tolerability and efficacy of SHR-A1811 in combinati...
Show More Location
Jiangsu Provincial People's Hospital
Learn More & Join Trial
A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer PHASE3 It is a randomized, open label, positive drug controlled, multicenter desig...
Show More Location
Cancer Hospital of Chinese Academy of Medical Sciences
Learn More & Join Trial
Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer Patients PHASE2 The study is being conducted to evaluate the preliminary efficacy, safety, ...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer PHASE2 This is a multi-cohort, multi-center Phase II clinical study exploring the ...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial